ArticleClinical immunology (Orlando, Fla.)2018

Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Yujuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.